Searchable abstracts of presentations at key conferences in endocrinology

ea0078p63 | Thyroid | BSPED2021

Conversion of hypothyroidism to hyperthyroidism – an interesting U-turn

Kaninde Abhidhamma , Greening James , Subbarayan Anbezhil

Background: Hashimoto’s thyroiditis and Grave’s disease are the common autoimmune diseases of thyroid gland across all age groups. Some patients with autoimmune hyperthyroidism can become hypothyroid however it is rare for patients with hypothyroidism to develop Grave’s disease. Although some cases have been reported in adults, this phenomenon is very rare in the paediatric age group. Case: 13 year old Caucasian girl who was diagnosed with...

ea0085oc8.1 | Oral Communications 8 | BSPED2022

Do we need earlier thyroid surveillance amongst PTEN patients in the UK?

Kaninde Abhidhamma , Kuo Michael , Ren Ong Kai , Barrett Timothy , Dias Renuka

Background: Germline mutations in the Phosphatase and Tensin Homolog Hamartoma tumour (PTEN) gene are associated with a number of conditions, collectively known as PTEN hamartoma tumour syndromes (PHTS). Individuals with PHTS are at increased risk of a number of cancers primarily in adulthood including differentiated thyroid carcinoma (DTC) with an estimated lifetime risk of DTC of up to 38%. International guidance recommends screening commencing from 17 years while the 2017-U...

ea0085p65 | Diabetes 3 | BSPED2022

Use of artificial pancreas systems in routine clinical care is effective in improving glycaemic control in paediatric patients

Kaninde Abhidhamma , Kotak Janki , Collins Louise , Drummond Lesley , Pemberton John , Idkowiak Jan , Mohamed Zainaba , Dias Renuka , Saraff Vrinda , Kershaw Melanie , Krone Ruth

Introduction: Artificial pancreas systems (APS) have improved glycaemic control in adult and paediatric patients in clinical trials as part of routine clinical careAim and objectives: To evaluate the effectiveness of artificial pancreas system in routine clinical care on glycaemic control over a period of three to six months. Changes in glycated haemoglobin (HbA1c), time in range (TIR, 3.9-10 mmol/l) and time below range (TBR, <3.9 mmol/l) were asses...